Literature DB >> 6254610

An autoradiographic study of human gliomas: growth kinetics of anaplastic astrocytoma and glioblastoma multiforme.

T Hoshino, J J Townsend, I Muraoka, C B Wilson.   

Abstract

When 3H-thymidine was administered either intravenously or intra-arterially to 9 patients with gliomas (5 glioblastoma multiforme, 3 anaplastic astrocytoma, and one mixed glioma) shortly before operation, and tissue obtained from the biopsy and, subsequently, at autopsy was examined by autoradiography, it was found that 2 of the glioblastomas diluted out the labelling in the two- to four-month interval between labelling and autopsy, whereas 3 other glioblastomas and the 2 anaplastic astrocytomas retained labelled neoplastic cells in parts of the tumours at autopsy after intervals of from three weeks to five months following labelling. Most patients whose tumours demonstrated foci of labelled cells at autopsy survived longer (1.5 to 7 years). Certain neoplastic cells in anaplastic astrocytomas and some glioblastomas appear either to limit cell division or to differentiate even in an environment favourable to cell proliferation.

Entities:  

Mesh:

Year:  1980        PMID: 6254610     DOI: 10.1093/brain/103.4.967

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  14 in total

1.  Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.

Authors:  M Deckert; G Reifenberger; W Wechsler
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

2.  A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.

Authors:  S Sharma; A K Karak; R Singh; V S Mehta; C Sarkar; H P Schmitt
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

3.  The vascular response to tumor infiltration in malignant gliomas. Morphometric and reconstruction study.

Authors:  D Schiffer; A Chiò; M T Giordana; A Mauro; A Migheli; M C Vigliani
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy.

Authors:  D Schiffer; M T Giordana; R Soffietti; R Sciolla
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

5.  Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67.

Authors:  F Giangaspero; C Doglioni; M T Rivano; S Pileri; J Gerdes; H Stein
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

6.  The future of chemotherapy in malignant brain tumors.

Authors:  L Calliauw; G Sieben
Journal:  Neurosurg Rev       Date:  1986       Impact factor: 3.042

7.  The future role of neurosurgery in the care of cerebral tumors.

Authors:  K Sano
Journal:  Neurosurg Rev       Date:  1986       Impact factor: 3.042

8.  Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme.

Authors:  K Onda; R L Davis; C B Wilson; T Hoshino
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Nuclear morphometry and DNA densitometry of human gliomas by image analysis.

Authors:  Y Yoshii; A Saito; T Nose
Journal:  J Neurooncol       Date:  1995-10       Impact factor: 4.130

10.  Rapid detection of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in 9L brain tumor cells in vitro and in situ.

Authors:  T Nagashima; T Hoshino
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.